En español
NIDA

Government Shutdown

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at USA.gov.

NIDA Notes Articles: HIV or AIDS

NIDA Notes Category Graphic

New Approach Uses Immune Cells To Deliver Anti-HIV Medications

October 2014
Nano-antiretroviral therapy (nano-ART) turns macrophages—one of the very cell types that HIV uses to replicate and spread through the body—into carriers for anti-HIV medications. The approach has the potential to make treatment for HIV easier and more effective.

NIDA Notes Category Graphic

Study Assesses Functional Deficits Due to HIV and Methamphetamine Use

November 2014
Methamphetamine use and HIV infection raise the risk for functional dependence, or the need for assistance with everyday tasks. People who use methamphetamine and are HIV positive showed the highest levels of functional dependence in most domains of daily life.

NIDA Notes Category Graphic

Distinct Challenges Affect Women’s HIV Treatment Outcomes After Jail

May 2015
Women who are infected with HIV and are transitioning back to communities after serving jail time are less likely than their male counterparts to have a regular HIV care provider, to take and regularly adhere to an HIV medication regimen, and to have suppression of the virus.

NIDA Notes Category Graphic

Gene Variant Is Associated With Reduced HIV Transmission

March 2016
A gene variant appears to partially shield people whose behaviors entail high risk for exposure to human immunodeficiency virus (HIV) from becoming infected.

NIDA Notes Category Graphic

Blocking Protein Complex May Lock Down HIV Reservoirs

September 2017
Inhibiting mTOR, a regulatory protein complex, can prevent reactivation of latent HIV. Medications to inhibit mTOR might help people with HIV achieve and maintain undetectable HIV viral loads.

Pages

NIDA Notes

Tags

Drug Topics

Drugs of Abuse

Population Groups

Related Topics